- Home
- NDAQ vs DXCM Comparison
NDAQ vs DXCM Comparison
Compare NDAQ & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDAQ
- DXCM
- Stock Information
- Founded
- NDAQ 1971
- DXCM 1999
- Country
- NDAQ United States
- DXCM United States
- Employees
- NDAQ N/A
- DXCM N/A
- Industry
- NDAQ Investment Bankers/Brokers/Service
- DXCM Medical/Dental Instruments
- Sector
- NDAQ Finance
- DXCM Health Care
- Exchange
- NDAQ Nasdaq
- DXCM Nasdaq
- Market Cap
- NDAQ 43.7B
- DXCM 32.7B
- IPO Year
- NDAQ 2002
- DXCM 2005
- Fundamental
- Price
- NDAQ $79.00
- DXCM $85.34
- Analyst Decision
- NDAQ Buy
- DXCM Strong Buy
- Analyst Count
- NDAQ 17
- DXCM 18
- Target Price
- NDAQ $86.00
- DXCM $98.11
- AVG Volume (30 Days)
- NDAQ 3.2M
- DXCM 4.7M
- Earning Date
- NDAQ 04-24-2025
- DXCM 05-01-2025
- Dividend Yield
- NDAQ 1.37%
- DXCM N/A
- EPS Growth
- NDAQ 18.52
- DXCM N/A
- EPS
- NDAQ 2.21
- DXCM 1.33
- Revenue
- NDAQ $7,816,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- NDAQ N/A
- DXCM $16.49
- Revenue Next Year
- NDAQ $7.13
- DXCM $15.45
- P/E Ratio
- NDAQ $35.74
- DXCM $64.06
- Revenue Growth
- NDAQ 25.96
- DXCM 9.11
- 52 Week Low
- NDAQ $58.28
- DXCM $57.52
- 52 Week High
- NDAQ $84.15
- DXCM $132.26
- Technical
- Relative Strength Index (RSI)
- NDAQ 63.68
- DXCM 72.77
- Support Level
- NDAQ $77.30
- DXCM $78.55
- Resistance Level
- NDAQ $78.58
- DXCM $72.60
- Average True Range (ATR)
- NDAQ 1.68
- DXCM 2.79
- MACD
- NDAQ 0.68
- DXCM 2.03
- Stochastic Oscillator
- NDAQ 87.78
- DXCM 98.06
About NDAQ Nasdaq Inc.
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.